| Oct 2 2023 |
CFPB Proposes Changes to Fair Credit Reporting Act to Remove Medical Debt from Credit Reports |
Greenberg Traurig, LLP |
| Oct 2 2023 |
CMS Proposes New All-Payor, Total-Cost-of-Care Model (AHEAD Model), Funding Opportunity for States |
Foley & Lardner LLP |
| Oct 2 2023 |
Old North State Report – Oct. 2, 2023 |
Nelson Mullins |
| Oct 2 2023 |
The Proposed MHPAEA Regulations’ ‘Meaning of Terms’ Part Two: Processes, Strategies, Evidentiary Standards and Other Factors |
McDermott Will & Emery |
| Oct 2 2023 |
FDA Proposes New Rule to Regulate Laboratory Developed Tests |
Nelson Mullins |
| Sep 29 2023 |
Weight-Loss Programs in Florida: State Law Considerations for GLP-1 Telehealth Providers |
McDermott Will & Emery |
| Sep 29 2023 |
The UPC Means Business: Latest Patentee Wins Preliminary Injunction |
McDermott Will & Emery |
| Sep 29 2023 |
McDermottPlus Check-Up: September 29, 2023 |
McDermott Will & Emery |
| Sep 29 2023 |
Lab Owner Sentenced to Over 16 Years for Health Care Fraud, Money Laundering |
ArentFox Schiff LLP |
| Sep 29 2023 |
Sixth Circuit Reverses Grants of Preliminary Injunctions in Gender Dysphoria Cases |
Squire Patton Boggs (US) LLP |
| Sep 28 2023 |
A Second Chance to Win Your Government Healthcare Contract |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 28 2023 |
Trending in Telehealth: September 19 – 25, 2023 |
McDermott Will & Emery |
| Sep 28 2023 |
Circuit Split on FCA Causation Deepens with Upcoming First Circuit Ruling |
Bradley Arant Boult Cummings LLP |
| Sep 28 2023 |
Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] |
Epstein Becker & Green, P.C. |
| Sep 28 2023 |
Medicare Advantage RADV Audit Final Rule Challenged in Court |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 27 2023 |
Overview of Recent Anti-Corruption Enforcement Actions in the Pharmaceutical Industry in China |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 27 2023 |
Questions to Consider as Regulators Increase Scrutiny of Medical Debt |
Bradley Arant Boult Cummings LLP |
| Sep 27 2023 |
Health Equity: An Important Pillar of ESG |
Katten |
| Sep 26 2023 |
Cal/OSHA’s Approach to Abatement: Addressing and Curing Workplace Hazards |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Sep 26 2023 |
FTC Sues Private Equity Firm and Anesthesiology Practice for Antitrust Violations |
Sheppard, Mullin, Richter & Hampton LLP |
| Sep 26 2023 |
The Proposed MHPAEA Regulations’ ‘Meaning of Terms’ Part One: Benefits |
McDermott Will & Emery |
| Sep 26 2023 |
Minnesota Seeks Comment on PFAS in Products Law |
Beveridge & Diamond PC |
| Sep 26 2023 |
U.S. Federal Trade Commission Challenges Private Equity Firm’s Acquisition Spree in Texas |
Squire Patton Boggs (US) LLP |
| Sep 26 2023 |
Medicaid Expansion in North Carolina |
Nelson Mullins |
| Sep 25 2023 |
What’s Next for Labor and Employment Laws in California? |
Foley & Lardner LLP |
| Sep 25 2023 |
Healthcare Preview for the Week of: September 25, 2023 |
McDermott Will & Emery |
| Sep 25 2023 |
Advisory Opinion 23-05: OIG Warns Sanctions Would Likely be Issued in Response to Certain Proposed Contractual Joint Venture |
Robinson & Cole LLP |
| Sep 25 2023 |
Just in Time for Flu Season, California Expands Sick Leave Requirements |
Proskauer Rose LLP |
| Sep 25 2023 |
CPSC Signals Interest in PFAS in Consumer Products |
Beveridge & Diamond PC |
| Sep 25 2023 |
Use of Artificial Intelligence in Healthcare Industry in Mainland China |
Squire Patton Boggs (US) LLP |
| Sep 22 2023 |
California Legislative Session Ends Without Any Major Tax Changes—But the 2024 Ballot Season Will be One to Watch |
Greenberg Traurig, LLP |
| Sep 22 2023 |
McDermottPlus Check-Up: September 22, 2023 |
McDermott Will & Emery |
| Sep 22 2023 |
Engineering Company Agrees to Pay $4.4 Million to Settle FCA |
ArentFox Schiff LLP |
| Sep 22 2023 |
Baker’s Dozen: Delaware Becomes 13th State to Enact State Consumer Privacy Law |
McDermott Will & Emery |
| Sep 22 2023 |
Trending in Telehealth: September 5 – 18, 2023 |
McDermott Will & Emery |
